TCA cycle is affected by oxaliplatin

TCA cycle is affected by oxaliplatin. E1 component of 2-oxoglutarate dehydrogenase complex (OGDH) enzyme (Ogdh) exhibited statistically significant downregulation. The remaining two subunits of this complex encoded by Dlst and Dld and other genes controlling the TCA cycle were not affected. The other enzymes of the TCA cycle remained unaffected by oxaliplatin. That includes citrate synthase (Cs) that converts acetyl-CoA from β-oxidation of FAs or from glycolysis to form citrate, aconitase isomerases (Aco1 and Aco2) that convert citrate to isocitrate, isocitrate dehydrogenases (Idh3b and Idh3g) that form 2-oxoglutaric acid, succinate coenzyme A ligase (Sucla2, Suclg1, Suclg2), succinate dehydrogenases (Sdha, Sdhb and Sdhc) that forms fumarate, fumarate hydratase 1 (Fh1) that produce malate, and mitochondrial malate dehydrogenases (Mdh1 and Mdh2) that form oxaloacetate. The pathway is derived from the KEGG database. Blue – upregulated genes, red downregulated genes, grey – not affected genes
TCA cycle is affected by oxaliplatin

Publication

Oxaliplatin-induced cardiotoxicity in mice is connected to the changes in energy metabolism in the heart tissue (2023) Junwei Du, et al. bioRxiv. 2023 May 25;NA(NA). Figure: F10.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID